Hongfei Tong
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 4
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 3
- Analytical Chemistry top 10%
-
- Phytochemistry and biological activity of medicinal plants 10
-
- Liver Disease and Transplantation 3
-
- Acute Myeloid Leukemia Research 3
-
- Acute Lymphoblastic Leukemia research 3
-
- Esophageal and GI Pathology 3
-
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Zhaohong WangSheng‐Zhang LinDIAN-LEI LIUShengzhang LinKangjie ChenHui ChenZhonglin NiHaibin Liu
- Journals
- PLoS ONE (3 papers)Life Sciences (1 paper)International Journal of Biological Sciences (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Hongfei Tong
36 papers receiving 857 citations
Peers
Comparison fields: 5 of 83
- Toxicology 82
- Pharmacology 86
- Cancer Research 141
- Molecular Biology 392
- Analytical Chemistry 53
Countries citing papers authored by Hongfei Tong
This map shows the geographic impact of Hongfei Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongfei Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongfei Tong more than expected).
Fields of papers citing papers by Hongfei Tong
This network shows the impact of papers produced by Hongfei Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongfei Tong. The network helps show where Hongfei Tong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongfei Tong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2022 | 13 | |
| 3 | 2020 | 15 | |
| 4 | 2020 | 3 | |
| 5 | 2019 | 26 | |
| 6 | 2019 | 16 | |
| 7 | Association of folypolyglutamate synthetase (FPGS) gene polymorphism with blood drug concentration as well as adverse reactions of methotrexate in children with acute leukaemia | 2017 | 3 |
| 8 | 2017 | 11 | |
| 9 | 2017 | 9 | |
| 10 | 2016 | 17 | |
| 11 | 2015 | 36 | |
| 12 | 2014 | 44 | |
| 13 | 2013 | 56 | |
| 14 | 2013 | 38 | |
| 15 | 2012 | 70 | |
| 16 | 2012 | 13 | |
| 17 | 2012 | 10 | |
| 18 | 2011 | 20 | |
| 19 | 2010 | 28 | |
| 20 | 2008 | 13 |
About Hongfei Tong
Hongfei Tong is a scholar working on Toxicology, Aging and Hepatology, having authored 36 papers that have together received 867 indexed citations. Recurring topics across this work include Phytochemistry and biological activity of medicinal plants (10 papers), Bioactive Compounds and Antitumor Agents (4 papers), Liver Disease and Transplantation (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Esophageal and GI Pathology (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Toxicology (82 citations), Pharmacology (86 citations) and Cancer Research (141 citations). Hongfei Tong has collaborated with scholars based in China and United States. Frequent co-authors include Zhaohong Wang, Sheng‐Zhang Lin, DIAN-LEI LIU, Shengzhang Lin, Kangjie Chen, Hui Chen, Zhonglin Ni, Haibin Liu, Hui Chen and Weitian Wei. Their work appears in journals such as PLoS ONE, Life Sciences and International Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.